Clinicians should resist the temptation to label patients with suspected recurrent VTE while on anticoagulant therapy as a true therapeutic failure. Professor Marc Rodger, head of haematology at the Ottawa Blood Disease Center, told the ISTH Congress that while suspected VTE on therapy was common, confirmed recurrent VTE was not. As a consequence, how to ...
Already a member?
Enter your email to keep reading.